CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...